AI-generated summary
The authors report on chromo- and laser therapy using infrared and green wavelengths, added to basal drug treatment, in patients with chronic obstructive pulmonary disease and arterial hypertension. They state the approach was associated with faster normalization of clinical characteristics, lower arterial pressure, better external respiration parameters, and longer remission periods.
- Who or what was studied
- Patients with chronic obstructive pulmonary disease and concomitant arterial hypertension
- Limits stated in the abstract
- The abstract does not state the number of patients, the study design, or any control group, so the findings cannot be assessed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.